Victoria Vakiener Sells 1,799 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Stock
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) Director Victoria Vakiener sold 1,799 shares of the firm’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $23.31, for a total value of $41,934.69. Following the completion of the sale, the director now owns 30,205 shares in the […]
More Stories
East West Petroleum (CVE:EW) Shares Up 28.6% – What’s Next?
East West Petroleum Corp. (CVE:EW – Get Free Report)’s share price shot up 28.6% during mid-day trading on Tuesday ....
Johnson & Johnson (NYSE:JNJ) Downgraded by StockNews.com to Buy
Johnson & Johnson (NYSE:JNJ – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating...
Credit Acceptance (NASDAQ:CACC) Cut to Hold at StockNews.com
Credit Acceptance (NASDAQ:CACC – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a...
TG Therapeutics (NASDAQ:TGTX) Rating Increased to Hold at StockNews.com
TG Therapeutics (NASDAQ:TGTX – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in...
Analyzing Simulations Plus (NASDAQ:SLP) and Veea (NASDAQ:VEEA)
Veea (NASDAQ:VEEA – Get Free Report) and Simulations Plus (NASDAQ:SLP – Get Free Report) are both small-cap computer and technology...
Rugby Resources (CVE:RUG) Shares Down 25% – Time to Sell?
Rugby Resources Ltd. (CVE:RUG – Get Free Report) shares traded down 25% on Tuesday . The company traded as low...